Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-05

Clinical Trial Update: Hepatic and Splenic Microcirculatory Perfusion for Ruling Out High-Risk Varices in Patients With Hepatitis B-Related Cirrhosis

View source ↗

Summary

A clinical trial is evaluating hepatic and splenic microcirculatory perfusion to help rule out high-risk esophagogastric varices in patients with hepatitis B vi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Hepatitis B Virus Related Cirrhosis, Portal Hypertension Related to Cirrhosis | Status: NOT_YET_RECRUITING